Total Funding
82
70
Total FundingSeries B raised
Growth Score
-7 pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
496965
TOPIGEN is a biotech company engaged in scientific research and development of novel therapeutic drugs.
About the Company
Topigen Pharmaceuticals is a biotechnology company that is focused on the scientific research and development of therapeutic drugs. It develops treatments for respiratory disorders, including asthma and chronic obstructive pulmonary disease.
Topigen Pharmaceuticals offers TPI ASM8, a drug that is developed for the management of moderate to severe
asthma; and TPI 1100, a drug that is developed for the chronic obstructive pulmonary disease.
Topigen Pharmaceuticals was acquired by Pharmaxis in January 2010.
Topigen Pharmaceuticals was founded in 2000 and is based in Montreal, Quebec.
